What is the price-to-earnings ratio of QMed?
The price-earnings ratio of QMed is currently 0.
QMed P/S 2024
QMed P/S
0
Ticker
QMED
ISIN
US7479141092
WKN
872968
As of Oct 1, 2024, QMed's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.
The QMed P/S history
QMed Aktienanalyse
What does QMed do?
QMed Inc is a US-American company specializing in the development and manufacturing of medical devices and products. The company was founded in 1983 by various experts in the medical field and has since had a long history in the medical industry. QMed Inc's main business model is to develop innovative medical products that enable doctors and medical professionals to perform their work more efficiently and effectively. This includes the production of disposable products such as catheters, injection needles, urine drainage bags, and special medical adhesives. The company is divided into several different divisions, each specializing in different medical fields. One of these divisions is the Bio-Patch Division, which specializes in the development of specialized wound dressings. These dressings can be applied to open wounds and help heal them and prevent infections. Another division of QMed Inc is the Urology Division. This division offers a wide range of urological products such as catheters and urine drainage bags. In addition, the company also has its own department for the production of injection systems and devices used by doctors and medical professionals in medication administration. Another important business area of QMed Inc. is the production of special adhesives used in the medical industry. These adhesives are used, for example, in securing dressings and catheters, ensuring that they adhere securely to the patient's body. Since its founding, QMed Inc has been a significant player in the medical industry and has an impressive track record. The company has received numerous awards and certifications over the years and is now globally recognized for its innovative products and high manufacturing quality. Although QMed Inc is now a globally operating company, it remains true to its roots and places great value on its employees and customers. The company is highly committed to research and development and works closely with medical institutions and professionals to continually bring new and improved products to the market. Overall, QMed Inc is a company distinguished by its long-standing experience in the medical industry, its high manufacturing quality, and its impressive range of products. The company is constantly working to improve its products and find new innovative solutions to help doctors and medical professionals make their work even more efficient and successful. QMed ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding QMed's P/S Ratio
QMed's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing QMed's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating QMed's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in QMed’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about QMed stock
How has the price-earnings ratio of QMed changed compared to last year?
The price-to-earnings ratio of QMed has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of QMed high compared to other companies?
Yes, the price-to-earnings ratio of QMed is high compared to other companies.
How does an increase in the price-earnings ratio of QMed affect the company?
An increase in the price-earnings ratio of QMed would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of QMed affect the company?
A decrease in the price-earnings ratio of QMed would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of QMed?
Some factors that influence the price-earnings ratio of QMed are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does QMed pay?
Over the past 12 months, QMed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, QMed is expected to pay a dividend of 0 USD.
What is the dividend yield of QMed?
The current dividend yield of QMed is .
When does QMed pay dividends?
QMed pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of QMed?
QMed paid dividends every year for the past 0 years.
What is the dividend of QMed?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is QMed located?
QMed is assigned to the 'Health' sector.
Wann musste ich die Aktien von QMed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of QMed from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.
When did QMed pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of QMed in the year 2023?
In the year 2023, QMed distributed 0 USD as dividends.
In which currency does QMed pay out the dividend?
The dividends of QMed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von QMed
Our stock analysis for QMed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of QMed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
